Takhzyro 150 MG
Ended Awarded
- Contract number
- 36C24526N0192
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $36,984
Award facts
- Contract value 100% obligated
- $36,984.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Brooks, KY 40109, USA
Award details come from SAM.gov/FPDS.
About this award
On December 16, 2025, the Department of Veterans Affairs Veterans Integrated Service Network 5 awarded a firm fixed-price delivery order valued at $36,984.28 to Takeda Pharmaceuticals America Inc. for the supply of TAKHZYRO 150 mg, a specialized pharmaceutical treatment for hereditary angioedema. This delivery order represents a child contract under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and carries an ultimate completion date of December 18, 2025. The contract was awarded without a set-aside designation, consistent with Takeda's typical procurement approach for specialized medications. Performance will occur in Brooks, Kentucky.
Takeda Pharmaceuticals America Inc., a subsidiary of Japan-based Takeda Pharmaceutical Company Limited, is a primary supplier of critical pharmaceutical products to federal healthcare agencies, particularly the Veterans Affairs system. This delivery order aligns with Takeda's existing Blanket Purchase Agreement with the VA National Acquisition Center valued at $131.0 million, which runs through July 2026 and enables streamlined procurement of advanced treatments for rare diseases and complex medical conditions. The company's federal contract portfolio demonstrates its established role in delivering specialized medications to support veteran healthcare and other federal patient care programs.
Quick answers
Who was awarded contract 36C24526N0192?
36C24526N0192 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on December 16, 2025.
How much is contract 36C24526N0192 worth?
The government has obligated $36,984 on 36C24526N0192.
Is contract 36C24526N0192 an order under another contract?
Yes. 36C24526N0192 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0192 competed?
The extent of competition for 36C24526N0192 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award